Evaluation of factors affecting vaccine efficacy of recombinant Marek's disease virus lacking the Meq oncogene in chickens

Avian Diseases

Volumn 55, Issue 2, 2011, Pages 172-179

  Lee, Lucy F ^a   Zhang, Huanmin ^a   Heidari, Mohammad ^a   Lupiani, Blanca ^b   Reddy, Sanjay M ^b  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Marek's disease virus; Meq oncogene; recombinant MDV; vaccine efficacy; vaccine parameters

Indexed keywords

ECO Q PROTEIN, GALLID HERPESVIRUS 2; ECO-Q PROTEIN, GALLID HERPESVIRUS 2; LIVE VACCINE; MAREK DISEASE VACCINE; ONCOPROTEIN;

ANIMAL; ARTICLE; CELL LINE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETICS; HAPLOTYPE; IMMUNOLOGY; MARDIVIRUS; MAREK DISEASE; METABOLISM; PATHOGENICITY; VIROLOGY; VIRULENCE;

ANIMALS; CELL LINE; CHICKENS; HAPLOTYPES; HERPESVIRUS 2, GALLID; MAREK DISEASE; MAREK DISEASE VACCINES; ONCOGENE PROTEINS, VIRAL; VACCINES, ATTENUATED; VIRULENCE;

GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 79959309153     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/9575-101510-Reg.1     Document Type: Article

References (42)

1. Afonso, C. L., E. R. Tulman, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish. The genome of turkey herpesvirus. J. Virol. 75:971-978. 2001. (Pubitemid 32037299)
2. Bacon, L. D., H. D. Hunt, and H. H. Cheng. Genetic resistance to Marek's disease. Curr. Top. Microbiol. Immunol. 255:121-141. 2001.
3. Bacon, L. D., H. D. Hunt, and H. H. Cheng. A review of the development of chicken lines to resolve genes determining resistance to disease. Poult. Sci. 79:1082-1093. 2000.
4. Bacon, L. D., and R. L. Witter. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines. Avian Dis. 38:65-71. 1994. (Pubitemid 2072623)
5. Briles, W. E., H. A. Stone, and R. K. Cole. Marek's disease: effects of B histocompatibility alloalleles in resistant and susceptible chicken lines. Science 195:193-195. 1977. (Pubitemid 8012003)
6. Brown, A. C., S. J. Baigent, L. P. Smith, J. P. Chattoo, L. J. Petherbridge, P. Hawes, M. J. Allday, and V. Nair. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc. Natl. Acad. Sci. U. S. A. 103:1687-1692. 2006. (Pubitemid 43228754)
7. Bublot, M., and J. Sharma. Vaccination against Marek's disease. In: Marek's disease an evolving problem. F. Davidson and V. Nair, eds. Elsevier Academic Press, London. pp. 168-185. 2004.
8. Churchill, A. E., and P. M. Biggs. Agent of Marek's disease in tissue culture. Nature 215:528-530. 1967.
9. Fakhrul Islam, A. F., S. W. Walkden-Brown, P. J. Groves, and G. J. Underwood. Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time. Avian Pathol. 37:225-235. 2008. (Pubitemid 351882790)
10. Geng, S., and F. J. Hills. Biometrics in agriculture science. Kendall /Hunt Publishing Company, Dubuque, IA. 1989.
11. Gimeno, I. M. Marek's disease vaccines: a solution for today but a worry for tomorrow? Vaccine 26(Suppl 3):C31-C41. 2008. (Pubitemid 351899088)
12. Islam, A. F., S. W. Walkden-Brown, P. J. Groves, and G. J. Underwood. Effects of vaccine dose, virus challenge dose and interval from vaccination to challenge on protection of broiler chickens against Marek's disease virus challenge. Aust. Vet. J. 85:348-355. 2007. (Pubitemid 47330517)
13. Izumiya, Y., H. K. Jang, M. Ono, and T. Mikami. A complete genomic DNA sequence of Marek's disease virus type 2, strain HPRS24. Curr. Top. Microbiol. Immunol. 255:191-221. 2001.
14. Jones, D., L. Lee, J. L. Liu, H. J. Kung, and J. K. Tillotson. Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc. Natl. Acad. Sci. U. S. A. 89:4042-4046. 1992.
15. King, D., D. Page, K. A. Schat, and B. W. Calnek. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines. Avian Dis. 25:74-81. 1981.
16. Kung, H. J., L. Xia, P. Brunovskis, D. Li, J. L. Liu, and L. F. Lee. Meq: an MD specific bZIP transactivator with transforming properties. Curr. Top. Microbiol. Immunol. 255:245-260. 2001. (Pubitemid 32011632)
17. Lee, L. F., K. S. Kreager, J. Arango, A. Paraguassu, B. Beckman, H. Zhang, A. Fadly, B. Lupiani, and S. M. Reddy. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens. Vaccine 28:1294-1299. 2010.
18. Lee, L. F., X. Liu, and R. L. Witter. Monoclonal antibodies with specificity for three different serotypes of Marek's disease viruses in chickens. J. Immunol. 130:1003-1006. 1983. (Pubitemid 13186343)
19. Lee, L. F., B. Lupiani, R. F. Silva, H. J. Kung, and S. M. Reddy. Recombinant Marek's disease virus (MDV) lacking the Meq oncogene confers protection against challenge with a very virulent plus strain of MDV. Vaccine 26:1887-1892. 2008.
20. Lee, L. F., P. Wu, D. Sui, D. Ren, J. Kamil, H. J. Kung, and R. L. Witter. The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. Proc. Natl. Acad. Sci. U. S. A. 97:6091-6096. 2000. (Pubitemid 30367528)
21. Levy, A. M., O. Gilad, L. Xia, Y. Izumiya, J. Choi, A. Tsalenko, Z. Yakhini, R. Witter, L. Lee, C. J. Cardona, and H. J. Kung. Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses. Proc. Natl. Acad. Sci. U. S. A. 102:14831-14836. 2005. (Pubitemid 41457141)
22. Lupiani, B., L. F. Lee, X. Cui, I. Gimeno, A. Anderson, R. W. Morgan, R. F. Silva, R. L. Witter, H. J. Kung, and S. M. Reddy. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. Proc. Natl. Acad. Sci. U. S. A. 101:11815-11820. 2004. (Pubitemid 39095377)
23. Nazerian, K., J. J. Solomon, R. L. Witter, and B. R. Burmester. Studies on the etiology of Marek's disease. II. Finding of a herpesvirus in cell culture. Proc. Soc. Exp. Biol. Med. 127:177-182. 1968.
24. Okazaki, W., H. G. Purchase, and B. R. Burmester. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 14:413-429. 1970.
25. Qian, Z., P. Brunovskis, L. F. Lee, P. K. Vogt, and H. J. Kung. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein. J. Virol. 70:7161-7170. 1996. (Pubitemid 26307433)
26. Qian, Z., P. Brunovskis, F. Rauscher III, L. F. Lee, and H. J. Kung. The transactivation activity of meq, a Marek's disease herpes virus b-ZIP protein persistently expressed in latently-infected transformed T-cells. J. Virol. 69:4037-4044. 1995.
27. Reddy, S. M., B. Lupiani, I. M. Gimeno, R. F. Silva, L. F. Lee, and R. L. Witter. Rescue of a pathogenic Marek's disease virus with overlapping cosmid DNAs: use of a pp38 mutant to validate the technology for the study of gene function. Proc. Natl. Acad. Sci. U. S. A. 99:7054-7059. 2002. (Pubitemid 34526254)
28. Rispens, B. H., H. Van Vloten, N. Mastenbroek, H. J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. I. Isolation of an avirulent Marek's disease virus (strain CVI 988) and its use in laboratory vaccination trials. Avian Dis. 16:108-125. 1972.
29. Rispens, B. H., H. Van Vloten, N. Mastenbroek, H. J. L. Maas, and K. A. Schat. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 16:126-138. 1972.
30. Schat, K. A., and B. W. Calnek. Characterization of an apparently nononcogenic Marek's disease virus. J. Natl. Cancer Inst. 60:1075-1082. 1978. (Pubitemid 8335952)
31. Schat, K. A., and V. Nair. Marek's disease. In: Diseases of poultry, 12th ed. Y. M. Saif, A. M. Fadly, J. R. Glisson, L. R. McDougald, L. K. Nolan, and D. E. Swayne, eds. Blackwell Publishing, Ames, IA. pp. 452-514. 2008.
32. Schumacher, D., B. K. Tischer, W. Fuchs, and N. Osterrieder. Reconstitution of Marek' disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterizaetion of a glycoprotein B-negative MDV-1 mutant. J. Virol. 74:11088-11098. 2000. (Pubitemid 32223974)
33. Sharma, J. M., and C. K. Graham. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine. Avian Dis. 26:860-870. 1982.
34. Silva, R. F., J. R. Dunn, H. H. Cheng, and M. Niikura. A MEQdeleted Marek's disease virus cloned as a bacterial artificial chromosome is a highly efficacious vaccine. Avian Dis. 54:862-869. 2010.
35. Tulman, E. R., C. L. Afonso, Z. Lu, L. Zsak, D. L. Rock, and G. F. Kutish. The genome of a very virulent Marek's disease virus. J Virol. 74:7980-7988. 2000. (Pubitemid 30641642)
36. Witter, R. L. Characteristics of Marek's disease virus isolated from vaccinated commercial chicken flocks: association of viral pathotypes with lymphoma frequency. Avian Dis. 27:113-132. 1983.
37. Witter, R. L. Increased virulence of Marek's disease virus field isolates. Avian Dis. 41:149-163. 1997. (Pubitemid 27153252)
38. Witter, R. L., and B. R. Burmester. Differential effect of maternal antibodies on efficacy of cellular and cell-free Marek's disease vaccines. Avian Pathol. 8:145-156. 1979.
39. Witter, R. L., B. W. Calnek, C. Buscaglia, I. M. Gimeno, and K. A. Schat. Classification of Marek's disease viruses according to pathotype: philosophy and methodology. Avian Pathol. 34:75-90. 2005. (Pubitemid 40589359)
40. Witter, R. L., and K. S. Kreager. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease. Avian Dis. 48:768-782. 2004. (Pubitemid 40059874)
41. Witter, R. L., and L. F. Lee. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies. Avian Pathol. 13:75-92. 1984.
42. Witter, R. L., K. Nazerian, H. G. Purchase, and G. H. Burgoyne. Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am. J. Vet. Res. 31:525-538. 1970.